A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
AstraZeneca
AstraZeneca
Tesaro, Inc.
Memgen, Inc.
Thomas Jefferson University
Eli Lilly and Company
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center